Raab & Moskowitz Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $757K | Hold |
1,701
| – | – | 0.18% | 102 |
|
2025
Q1 | $825K | Hold |
1,701
| – | – | 0.21% | 94 |
|
2024
Q4 | $685K | Sell |
1,701
-48
| -3% | -$19.3K | 0.17% | 103 |
|
2024
Q3 | $813K | Sell |
1,749
-37
| -2% | -$17.2K | 0.21% | 93 |
|
2024
Q2 | $837K | Buy |
1,786
+48
| +3% | +$22.5K | 0.23% | 87 |
|
2024
Q1 | $727K | Hold |
1,738
| – | – | 0.2% | 95 |
|
2023
Q4 | $707K | Sell |
1,738
-27
| -2% | -$11K | 0.22% | 93 |
|
2023
Q3 | $614K | Hold |
1,765
| – | – | 0.22% | 95 |
|
2023
Q2 | $621K | Hold |
1,765
| – | – | 0.21% | 94 |
|
2023
Q1 | $556K | Sell |
1,765
-58
| -3% | -$18.3K | 0.2% | 98 |
|
2022
Q4 | $526K | Buy |
1,823
+125
| +7% | +$36.1K | 0.2% | 101 |
|
2022
Q3 | $491K | Sell |
1,698
-5
| -0.3% | -$1.45K | 0.21% | 101 |
|
2022
Q2 | $479K | Hold |
1,703
| – | – | 0.19% | 111 |
|
2022
Q1 | $444K | Buy |
1,703
+50
| +3% | +$13K | 0.15% | 118 |
|
2021
Q4 | $363K | Hold |
1,653
| – | – | 0.12% | 129 |
|
2021
Q3 | $300K | Hold |
1,653
| – | – | 0.11% | 137 |
|
2021
Q2 | $333K | Hold |
1,653
| – | – | 0.12% | 130 |
|
2021
Q1 | $355K | Buy |
1,653
+15
| +0.9% | +$3.22K | 0.14% | 115 |
|
2020
Q4 | $387K | Sell |
1,638
-6
| -0.4% | -$1.42K | 0.16% | 111 |
|
2020
Q3 | $447K | Buy |
1,644
+4
| +0.2% | +$1.09K | 0.21% | 99 |
|
2020
Q2 | $476K | Sell |
1,640
-28
| -2% | -$8.13K | 0.23% | 95 |
|
2020
Q1 | $396K | Hold |
1,668
| – | – | 0.22% | 98 |
|
2019
Q4 | $365K | Hold |
1,668
| – | – | 0.14% | 122 |
|
2019
Q3 | $282K | Hold |
1,668
| – | – | 0.12% | 135 |
|
2019
Q2 | $305K | Hold |
1,668
| – | – | 0.14% | 132 |
|
2019
Q1 | $306K | Hold |
1,668
| – | – | 0.14% | 130 |
|
2018
Q4 | $276K | Hold |
1,668
| – | – | 0.14% | 130 |
|
2018
Q3 | $321K | Hold |
1,668
| – | – | 0.13% | 129 |
|
2018
Q2 | $283K | Hold |
1,668
| – | – | 0.14% | 129 |
|
2018
Q1 | $271K | Buy |
+1,668
| New | +$271K | 0.13% | 130 |
|